(Q43636591)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Kramm CM

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Banning U

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Riemann D

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Holzhausen HJ

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Heidecke V

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Burger KJ

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Burkert W

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Körholz D

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1853-1858

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301311

2 November 2019

exact match

0 references

cites work

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

Ganciclovir chemoablation of herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

MRI characteristics and histological changes in glioblastoma after gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

Levels of soluble Fas ligand in myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

Molecular evaluation of biopsy and autopsy specimens from patients receiving in vivo retroviral gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

Gene therapy for malignant glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

7 January 2021

Increased blood concentrations of interleukin-12 are associated with a longer survival in untreatable metastatic solid tumor patients: preliminary observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

7 January 2021

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

7 January 2021

Peripheral blood monocytes of rheumatoid arthritis patients do not express elevated TNF α, IL-1β, and IL-8 mRNA levels. A comparison of monocyte isolation procedures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301311

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11110418%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 November 2019

0 references

1 reference